摘要
多靶点药物对特定多靶点具有较好的保护性、抵抗力和治疗作用,其关键靶点是具有抵抗行为和代偿因素的合作规则。计算技术可以帮助我们在早期阶段努力设计新的药物(配体)的首选生物活性轮廓和替代生物活性分子。一批在硅片的方法已被广泛的探索以促进个人目标代理商的调查提出了一个选择性的药物。一个不同的,逐步更重要的领域是用来预测生物活性化合物的数据挖掘方法。前面提到的一些方法已经研究了多靶点药物设计(医疗损害纠纷)发现药物导致的相互作用同时与多个目标。一些化学信息学的方法和基于结构的方法来提取信息,从单位合作在生物系统来完成他们的任务。占主导地位的配体的目标结构,实验规范的困境的合理方法,即分子对接,SAR和QSAR是获得知识对每个结构中原子的洞察力至关重要的替代品。这些程序在逻辑上是成功的结合亲和力的预测和促进医疗损害纠纷有良好的前景。在这里,我们回顾了一些使用的计算方法的多靶点治疗药物发现的重要特征,突出了SAR,QSAR,对接和药效的方法发现的药物靶标之间的相互作用可以用于治疗的好处。每一个总结,其次是在药物设计中的应用实例。每个方法的计算效率已表示根据其主要优点和局限性。
关键词: 多靶点、药物设计、电子、SAR、构效关系、分子对接。
图形摘要
Current Drug Targets
Title:Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods
Volume: 18 Issue: 5
关键词: 多靶点、药物设计、电子、SAR、构效关系、分子对接。
摘要: Multi-target drugs against particular multiple targets get better protection, resistance profiles and curative influence by cooperative rules of a key beneficial target with resistance behavior and compensatory elements. Computational techniques can assist us in the efforts to design novel drugs (ligands) with a preferred bioactivity outline and alternative bioactive molecules at an early stage. A number of in silico methods have been explored extensively in order to facilitate the investigation of individual target agents and to propose a selective drug. A different, progressively more significant field which is used to predict the bioactivity of chemical compounds is the data mining method. Some of the previously mentioned methods have been investigated for multi-target drug design (MTDD) to find drug leads interact simultaneously with multiple targets. Several cheminformatics methods and structure-based approaches try to extract information from units working cooperatively in a biomolecular system to fulfill their task. To dominate the difficulties of the experimental specification of ligand-target structures, rational methods, namely molecular docking, SAR and QSAR are vital substitutes to obtain knowledge for each structure in atomic insight. These procedures are logically successful for the prediction of binding affinity and have shown promising potential in facilitating MTDD. Here, we review some of the important features of the multi-target therapeutics discoveries using the computational approach, highlighting the SAR, QSAR, docking and pharmacophore methods to discover interactions between drug-target that could be leveraged for curative benefits. A summary of each, followed by examples of its applications in drug design has been provided. Computational efficiency of each method has been represented according to its main strengths and limitations.
Export Options
About this article
Cite this article as:
Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods, Current Drug Targets 2017; 18 (5) . https://dx.doi.org/10.2174/1389450117666160101120822
DOI https://dx.doi.org/10.2174/1389450117666160101120822 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System
Current Neurovascular Research Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Solvent-Free Synthesis of 4,5-Dihydropyrano[c]chromene Derivatives Over TiO<sub>2</sub> Nanoparticles as an Economical and Efficient Catalyst
Current Catalysis Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Melatonin: Pharmacology, Functions and Therapeutic Benefits
Current Neuropharmacology Exploring the Role of Gene Therapy for Neurological Disorders
Current Gene Therapy Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium
Current Drug Metabolism Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines
Current Drug Targets Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological Disorders
Current Alzheimer Research Old Friends in New Constellations - the Hematopoetic Growth Factors G-CSF, GMCSF, and EPO for the Treatment of Neurological Diseases
Current Medicinal Chemistry Biological and Pharmacological Effects of Gamma-oryzanol: An Updated Review of the Molecular Mechanisms
Current Pharmaceutical Design Stem Cells and Translational Medicine: From Research to Clinical Procedures
Current Tissue Engineering (Discontinued) Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
Current Neuropharmacology Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Current Pharmaceutical Design Neural Stem Cell Transplantation and CNS Diseases
CNS & Neurological Disorders - Drug Targets Possible Therapeutic Targets in Cardiac Myocyte Apoptosis
Current Pharmaceutical Design Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design